Dan DeMars is a partner and senior consultant for The Viridis Group He has spent over 25 years in the biomedical field, including research (basic and applied), clinical medicine (hospital/medical laboratory science), new product development, sales, marketing, project management, finance, and strategic management.
Mr. DeMars has held management positions with Glaxo (now GlaxoSmithKline), Miles (now Bayer), ClinTrials Research and PharmaResearch Corporation (two contract research organizations since acquired by Inveresk Research). His extensive experience has covered all areas of new biomedical product development, including academic (“bench”) research, clinical trials design and management, protocol conception and development, medical writing (manuscripts, abstracts, summary reports, IND/NDA sections, package inserts) and the vital transition between R&D and marketing. Mr. DeMars has a deep appreciation of the important – yet often overlooked – link between academia and the private sector in new product development, as he successfully established and directed an Office of Biomedical Industry Relations at a US medical school.
His primary business interests are: (1) serving the emerging biotechnology firm, most notably in – but not limited to – the therapeutic areas of oncology, immunology, infectious disease, and the rapidly-evolving field of genetics/genomics, (2) facilitating strategic relationships between academic biomedical investigators and private-sector biomedical (biotech, pharma, device, genomics) firms, and (3) providing due diligence to venture capital firms and angel investors on the scientific viability of biotech companies they are evaluating.
Mr. DeMars holds a Bachelor of Science degree in Chemistry, a Master of Science degree in Pathology and a Master of Business Administration degree.
